New registry tracks Stent-Graft device in Real-World use
NCT ID NCT04907240
First seen Feb 02, 2026 · Last updated Jun 20, 2026 · Updated 18 times
Summary
This registry is collecting information on how a special stent-graft device (GORE VIABAHN with PROPATEN surface) performs in everyday medical practice. It includes about 614 people with conditions like peripheral artery disease, aneurysms, or dialysis access problems. The goal is to see how safe and effective the device is outside of controlled clinical trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Alvaro Cunqueiro Hospital
Vigo, 36213, Spain
-
Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona
Ancona, 60127, Italy
-
Cardioangiologisches Centrum Bethanien
Frankfurt, 60389, Germany
-
Centre Hospitalier Regional Universitaire de Brest
Brest, 29200, France
-
Centre Hospitalier Unversitaire d'Angers
Angers, 49933, France
-
Clinique RHENA
Strasbourg, 67000, France
-
Dipartimento di Scienze Chirurgiche e Morfologiche
Varese, 21100, Italy
-
Fondazione Poliambulanza
Brescia, 25124, Italy
-
Greater Glasgow Health Board
Glasgow, G12 0XH, United Kingdom
-
Hopital Edouard Herriot (HCL)
Lyon, 69002, France
-
Hospital Paris Saint-Joseph
Paris, 75014, France
-
Hospital Universitari Germans Trias i Pujol
Barcelona, 08916, Spain
-
Karolinska University Hospital
Solna, 171 64, Sweden
-
Krankenhaus Reinbek St. Adolf-Stift
Reinbek, 21465, Germany
-
Marien Krankenhaus
Hamburg, 22087, Germany
-
Medical Center Leeuwarden
Leeuwarden, 8934 AD, Netherlands
-
Ospedale San Giovanni Molinette
Torino, 10126, Italy
-
Papageorgiou Hospital
Pávlos, 564 29, Greece
-
Queen Elizabeth Hospital
London, SE18 4QH, United Kingdom
-
Rijnstate
Arnhem, 6800 TA, Netherlands
-
S.C. Chirurgia Vascolare dell'A.O.U. di Modena
Modena, 41124, Italy
-
Skane University Hospital
Malmö, SE-205 02, Sweden
-
Southmead Hospital
Bristol, BS10 5NB, United Kingdom
-
University Hospital Tuebingen
Tübingen, 72076, Germany
-
University of Heidelberg
Heidelberg, D-69120, Germany
-
iD3 Medical cvba
Sint-Agatha-Berchem, 1082, Belgium
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface (VSX) (a stent-graft device)
What this could lead to
If successful, this registry could provide real-world evidence on the safety and effectiveness of this device for treating peripheral artery disease and other vascular conditions.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove cause and effect. Results may be influenced by patient selection and routine clinical practice variations.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.